Euclidean Capital LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
Euclidean Capital LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,006,592
-66.0%
657,8990.0%0.25%
-66.7%
Q1 2024$5,907,933
-63.9%
657,8990.0%0.76%
-58.9%
Q4 2023$16,348,790
-25.2%
657,899
-50.0%
1.84%
-22.9%
Q3 2023$21,868,562
+104.7%
1,315,798
+130.3%
2.39%
-13.1%
Q2 2023$10,682,057
+34.5%
571,233
+32.0%
2.74%
-60.6%
Q1 2023$7,943,715
-7.3%
432,9000.0%6.97%
-13.1%
Q4 2022$8,571,420
-17.7%
432,9000.0%8.02%
-17.1%
Q3 2022$10,416,000
+31.8%
432,9000.0%9.67%
+43.9%
Q2 2022$7,900,000
-17.0%
432,9000.0%6.72%
+21.5%
Q1 2022$9,519,000
-40.1%
432,9000.0%5.53%
-38.8%
Q4 2021$15,900,000
-19.4%
432,900
-31.8%
9.04%
-5.7%
Q3 2021$19,722,000
-15.7%
635,177
-13.7%
9.59%
+26.3%
Q2 2021$23,391,000
+43.2%
735,8010.0%7.59%
+38.9%
Q1 2021$16,335,000
+12.4%
735,8010.0%5.46%
+77.7%
Q4 2020$14,532,000735,8013.08%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$53,076,29617.67%
Euclidean Capital LLC 432,900$8,571,4208.02%
GREAT POINT PARTNERS LLC 1,436,569$28,444,0665.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 880,000$17,424,0003.47%
Trustees of Columbia University in the City of New York 73,383$1,4533.00%
Cheyne Capital Management (UK) LLP 71,828$1,422,1942.48%
Deep Track Capital, LP 1,304,940$25,837,8121.08%
Ghost Tree Capital, LLC 125,000$2,475,0001.06%
Perceptive Advisors 1,798,955$35,619,3091.00%
BRAIDWELL LP 1,000,000$19,800,0000.66%
View complete list of RAPT THERAPEUTICS INC shareholders